Jefferies Financial Group Inc. Buys New Position in Danaher Corporation $DHR

Jefferies Financial Group Inc. bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,241 shares of the conglomerate’s stock, valued at approximately $4,494,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Sivia Capital Partners LLC raised its holdings in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP lifted its position in shares of Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after acquiring an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC grew its holdings in shares of Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after acquiring an additional 886 shares during the last quarter. Ieq Capital LLC raised its position in shares of Danaher by 64.2% during the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after purchasing an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC boosted its position in shares of Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 0.3%

Shares of DHR stock opened at $216.41 on Friday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock has a 50 day moving average of $199.46 and a 200-day moving average of $192.52. The firm has a market cap of $152.13 billion, a PE ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 EPS. On average, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of recent analyst reports. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Citigroup assumed coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Piper Sandler started coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Finally, TD Cowen dropped their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.